Xiaoling Li
- Geriatrics and Gerontology top 0.05%
- Sirtuins and Resveratrol in Medicine 35
- Cancer Research top 0.05%
- Cancer-related molecular mechanisms research 56
- MicroRNA in disease regulation 29
- Molecular Biology top 0.2%
- RNA modifications and cancer 57
- RNA Research and Splicing 23
- RNA Interference and Gene Delivery 22
- Circular RNAs in diseases 22
- Oncology top 0.5%
- Immunology top 0.5%
-
- Selenium in Biological Systems 20
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Xiaoling Li
405 papers receiving 22.6k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Geriatrics and Gerontology 2.3k
- Cancer Research 6.6k
- Molecular Biology 13.0k
- Oncology 3.8k
- Immunology 2.7k
Countries citing papers authored by Xiaoling Li
This map shows the geographic impact of Xiaoling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Li more than expected).
Fields of papers citing papers by Xiaoling Li
This network shows the impact of papers produced by Xiaoling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Li. The network helps show where Xiaoling Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 17 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 13 | |
| 10 | 2023 | 12 | |
| 11 | 2021 | 29 | |
| 12 | 2021 | 15 | |
| 13 | 2020 | 218 | |
| 14 | 2017 | 27 | |
| 15 | 2016 | 5 | |
| 16 | 2013 | 84 | |
| 17 | 2012 | 17 | |
| 18 | 2012 | 58 | |
| 19 | 2011 | 61 | |
| 20 | [Functional genomics of nasopharyngeal carcinoma susceptibility/suppressor gene]. | 2008 | 2 |
About Xiaoling Li
Xiaoling Li is a scholar working on Geriatrics and Gerontology, Cancer Research, Molecular Biology, Immunology and Oncology, having authored 425 papers that have together received 22.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (57 papers), Cancer-related molecular mechanisms research (56 papers), Sirtuins and Resveratrol in Medicine (35 papers), MicroRNA in disease regulation (29 papers), RNA Research and Splicing (23 papers), RNA Interference and Gene Delivery (22 papers), Circular RNAs in diseases (22 papers) and Selenium in Biological Systems (20 papers). The work is most often cited by research in Geriatrics and Gerontology (2.3k citations), Cancer Research (6.6k citations), Molecular Biology (13.0k citations), Oncology (3.8k citations) and Immunology (2.7k citations). Xiaoling Li has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Guiyuan Li, Zhaoyang Zeng, Wei Xiong, Thaddeus T. Schug, Bo Xiang, Yong Li, Stephen J. Gould, Can Guo, Tianfeng Chen and Qing Xu. Their work appears in journals such as Journal of Cancer, Oncotarget, Molecular Cancer, Journal of Experimental & Clinical Cancer Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.